BTS
TEVA icon

BB&T Securities’s Teva Pharmaceuticals TEVA Stock Holding History

BB&T Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$157K Buy
+22,824
New +$175K ﹤0.01% 1541
2018
Q4 		– Sell
-30,610
Closed -$659K – 1606
2018
Q3 		$659K Sell
30,610
-16,959
-36% -$394K 0.01% 965
2018
Q2 		$1.16M Buy
47,569
+22,574
+90% +$460K 0.01% 761
2018
Q1 		$427K Sell
24,995
-32,668
-57% -$638K ﹤0.01% 1086
2017
Q4 		$1.09M Sell
57,663
-55,280
-49% -$832K 0.01% 723
2017
Q3 		$1.99M Buy
112,943
+93,630
+485% +$2.11M 0.03% 531
2017
Q2 		$641K Buy
19,313
+8,708
+82% +$270K 0.01% 892
2017
Q1 		$340K Buy
10,605
+2,766
+35% +$94.4K ﹤0.01% 1007
2016
Q4 		$360K Hold
7,839
– – 0.01% 951
2016
Q3 		$360K Sell
7,839
-925
-11% -$48.3K 0.01% 951
2016
Q2 		$440K Buy
8,764
+579
+7% +$30.8K 0.01% 846
2016
Q1 		$437K Sell
8,185
-5,719
-41% -$336K 0.01% 812
2015
Q4 		$912K Buy
13,904
+7,569
+119% +$468K 0.02% 551
2015
Q3 		$357K Sell
6,335
-1,474
-19% -$95.6K 0.01% 806
2015
Q2 		$461K Buy
7,809
+106
+1% +$6.54K 0.01% 778
2015
Q1 		$480K Sell
7,703
-774
-9% -$45K 0.01% 729
2014
Q4 		$488K Buy
8,477
+133
+2% +$7.41K 0.01% 712
2014
Q3 		$448K Sell
8,344
-644
-7% -$34.1K 0.01% 715
2014
Q2 		$471K Sell
8,988
-1,719
-16% -$87.9K 0.01% 684
2014
Q1 		$566K Sell
10,707
-440,619
-98% -$20.4M 0.01% 560
2013
Q4 		$18.1M Sell
451,326
-154,416
-25% -$6.08M 0.5% 56
2013
Q3 		$22.9M Buy
605,742
+6,676
+1% +$260K 0.71% 48
2013
Q2 		$23.5M Buy
+599,066
New +$23.3M 0.77% 42

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

BB&T Securities's TEVA Position: Q3 2019 in Review

BB&T Securities opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2019: 22,824 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #1541 among its holdings. This is a return to the name: BB&T Securities previously reported a position in TEVA as recently as Q3 2018.

BB&T Securities first reported a position in TEVA in Q2 2013 and has held it in 23 quarters since. The position peaked at $23.5M in Q2 2013. 428 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • BB&T Securities held 22,824 shares of Teva Pharmaceuticals worth $157K as of Q3 2019.
  • Teva Pharmaceuticals was a new BB&T Securities position in Q3 2019.
  • Teva Pharmaceuticals made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1541 holding.
  • BB&T Securities first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
  • BB&T Securities's Teva Pharmaceuticals position peaked at $23.5M in Q2 2013.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.